Persistent atrial fibrillation (AFib) has long been a challenging cardiac condition to treat. Affecting millions worldwide, its complexities often stump ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

To that end, VITAS has become the first nationwide hospice provider to earn the American Heart Association ® Palliative/Hospice Heart Failure certification across all 15 states in which it operates.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

Myotonic dystrophy type 1 (DM1) is the most common adult-onset form of muscular dystrophy and a condition that severely ...

Boise, Idaho-based St. Luke’s Regional Medical Center had the lowest heart failure readmission ratio between July 1, 2020, and June 30, 2023, according to CMS data published Feb. 19. As part of its ...

The PREDICT-HFpEF tool predicts cardiovascular risk, and finerenone remains effective for heart failure across baseline risk levels.

Aggressive ablation shows better clinical outcomes than regular ablation in patients with persistent atrial fibrillation.

After joining Cleveland-based University Hospitals in 2020 as UH Cleveland Medical Center’s director of cardiothoracic transplantation, Yasir Abu-Omar, MD, PhD, in February was appointed chief of ...

Obstructive sleep apnoea (OSA) is associated with an increased risk of all‐cause and cardiovascular mortality.1 Positive ...